expand_more
info

Due to high demand, supplies of Beyfortus are limited this season. We are working with the CDC to fairly distribute all remaining doses.

close

That's why there's Beyfortus (nirsevimab-alip) 50 mg and 100 mg injection

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:
  • Newborns and babies under 1 year of age born during or entering their first RSV season.
  • Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.

Baby with ECG stickers on chest

Babies are 16x more likely to be hospitalized with serious RSV lung infection than the flu

Most of the time RSV will cause a mild, cold-like illness. And while serious RSV lung infection is rare, it can lead to hospitalization. The best time to learn about RSV is now.

Learn More About RSVarrow_forward
Happy mom and baby in car seat

An extra layer of protection against serious lung infection caused by RSV

Beyfortus gives babies fast-acting protection to help prevent serious RSV lung infections like pneumonia.

Learn More About Beyfortusarrow_forward

Beyfortus is recommended by the American Academy of Pediatrics (AAP)

Happy parents with baby squezzing mom's nose

Is my baby eligible to get Beyfortus at no cost?

Beyfortus is part of the approved immunization schedule for babies and is covered by the Vaccines for Children (VFC) program and many private health insurance plans.

Explore Cost & Coveragearrow_forward

How you can take action today

IMPORTANT SAFETY INFORMATION

Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.
Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip

INDICATION

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in: